CCL Products (India) shareholding pattern

CCL

1014.95

18.80 (-1.82%)
Last updated on 27 Feb, 2026 | 15:56 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

CCL Products (India) Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

46.11%

Mutual Fund

19.22%

Insurance

0.06%

Foreign Institutional Investors

11.01%

Domestic Institutional Investors

2.25%

Retail

21.35%

Others

0%

Total Promoters
MAR '25
46.09%
JUN '25
46.09%
SEP '25
46.11%
DEC '25
46.11%

Summary

For Year 2025-26, CCL Products (India) reports the following shareholding: Total Promoters at 46.11%, Mutual Fund at 19.22%, Insurance at 0.06%, Foreign Institutional Investors at 11.01%, Domestic Institutional Investors at 2.25%, and Retail at 21.35%. This breakdown provides a quick snapshot of ownership distribution for CCL Products (India) in 2025-26.

CCL Products (India) FAQs

As of 03-2026, the promoter shareholding in CCL Products (India) stands at 46.11% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of CCL Products (India) is 11.01% and 2.25% respectively.

The retail shareholding of the CCL Products (India) is 21.35%.

Changes in shareholding patterns of CCL Products (India) can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of CCL Products (India) are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost